SQI Diagnostics (SQIDF) Stock Price, News & Analysis

Company Overview

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.0149 to $0.0149
• 50-Day Range: $0.0149 to $0.0149
• 52-Week Range: $0.01 to $0.13
• Volume: N/A
• Average Volume: 165,179 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SQIDF Stock Analysis - Frequently Asked Questions

How have SQIDF shares performed this year?

SQI Diagnostics' stock was trading at $0.0149 at the beginning of 2025. Since then, SQIDF stock has increased by 0.0% and is now trading at $0.0149.
View the best growth stocks for 2025 here.

How were SQI Diagnostics' earnings last quarter?

SQI Diagnostics Inc. (OTCMKTS:SQIDF) released its earnings results on Tuesday, January, 28th. The company reported ($0.03) EPS for the quarter.

How do I buy shares of SQI Diagnostics?

Shares of SQIDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 1/28/2014
• Today: 6/22/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SQIDF
• CIK: N/A
• Web: www.sqidiagnostics.com
• Phone: (416) 674-9500
• Fax: N/A
• Employees: 42
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A